Hematology deals with the diagnosis, study and treatment of disorders related to blood. Hematology diagnoses problems associated with red blood cells, white blood cells, bone marrow, platelets and lymph nodes. Hematology also transacts with the runny portion of blood also known as plasma. Some blood-related disorders are leukemia, anemia, blood transfusion, myelofibrosis, bone marrow stem cell transplantation and malignant lymphomas among others. Hematology analyzers, flow cytometers, coagulation analyzers, hematology reagents and slide strainers are some of the major and the most widely used hematologic instruments for analyzing the blood-related diseases. Hematology analyzers are extremely particular devices which are generally used to count the number of red blood cells, white blood cells and platelets. Hematology analyzers are designed with multiple analytical modules along with a unique sample preparation method. Hematology analyzers contribute in the diagnosis of several diseases, such as anemia, infections, diabetes, viruses, cancer and other genetic problems. They also help in regulating drug level of plasma for both illicit and therapeutic drugs. Moreover, fully automated hematology analyzers as well as semi automated analyzers are the two major types of hematology analyzers and reagents available and are totally dependent on the type of automation. Pale skin, fatigue and short of breath accompanied by exertion are some of the mutual symptoms of blood diseases. Clinical testing hospitals, laboratories and research centers are some of the key end-users of hematology analyzers and reagents.

Rising adoption of automated and semi-automated hematology instruments as well as increasing number of technological advancements are some major aspects driving the growth of the global hematology analyzers and reagents market. In addition, integration of basic flow cytometry methods in contemporary hematology analyzers are some of the major aspects fueling the hematology analyzer and reagents market. Also, increasing demand for high throughput hematology analyzers coupled with development of high sensitivity point of care hematology analyzers are also driving the growth of the global hematology analyzers and reagents market. However, high cost of instruments and extreme competition among existing market players are some of the key factors anticipated to hamper the growth of the global market. Moreover stringent regulatory policies might also hinder the market growth.

The global hematology analyzers and reagents market can be segmented on the basis of product type, end-user and geography. By product type, the global hematology analyzers and reagents market can be segmented into hemostasis instruments market and hemostasis reagents market. On the basis of end-user, the global hematology analyzers and reagents market can be segmented into clinical testing laboratories, stand-alone hospitals, research institutions and commercial organizations. On the basis of geography, the global hematology analyzers and reagents market can be segmented into North America, Europe, Asia-Pacific and Rest of the world.

Some of the major players in the global hematology analyzers and reagents market include Sysmex Corporation, Abbott Diagnostics, HORIBA, Beckman Coulter, Bio-Rad Laboratories, Siemens AG, Cholestech Corporation, Bayer Healthcare, Horiba Group and Heska Corporation among others.